483
Kerry Inc.Kerry Inc. – FDA 483, Feb 21, 2019
Record Details
An FDA inspection of Kerry Inc. in Fort Worth, TX, a seafood manufacturer, revealed significant deficiencies in its HACCP plan. The firm's plan lacked adequate verification procedures for critical control points, failed to identify Clostridium botulinum as a reasonably likely food safety hazard for certain products, and included an insufficient corrective action plan that did not address regaining control of operations after deviations.
- Office
- Dallas District Office
- Person
View Company Profile
ID · 41b0e15c-7542-40af-a0f5-07cf6f0be4ba
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.